Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

069620.KS


Top 10 Correlated ETFs

069620.KS


Top 10 Correlated Stocks

069620.KS


Financial details

Company Rating
Strong Buy
Market Cap
1876.23B
Income
72.73B
Revenue
1214.08B
Book val./share
55351.72
Cash/share
15406.89
Dividend
600
Dividend %
0.38%
Employees
1.53K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2022
P/E
23.97
Forward P/E
-
PEG
0.53
P/S
1.44
P/B
2.85
P/C
10.22
P/FCF
-5412.38
Quick Ratio
0.41
Current Ratio
1.38
Debt / Equity
0.41
LT Debt / Equity
0.34
-
-
EPS (TTM)
6.57K
EPS next Y
-
EPS next Q
-
EPS this Y
93.38%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-5.44%
Revenue last 5Y
3.72%
Revenue Q/Q
7.94%
EPS Q/Q
28.27%
-
-
-
-
SMA20
-3.57%
SMA50
-4.78%
SMA100
-3.66%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
13%
ROC
0.09%
Gross Margin
48%
Oper. Margin
8%
Profit Margin
6%
Payout
9%
Shs Outstand
11.07M
Shs Float
5.44M
-
-
-
-
Target Price
-
52W Range
127000.0-195500.0
52W High
-19.44%
52W Low
+24.02%
RSI
33.32
Rel Volume
1.25
Avg Volume
34.61K
Volume
43.18K
Perf Week
-9.74%
Perf Month
-12.26%
Perf Quarter
-3.96%
Perf Half Y
-3.96%
-
-
-
-
Beta
1.34444
-
-
Volatility
4435.48%, 5511.7%
Prev Close
-4.26%
Price
157500
Change
-4.26%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
93.05K99.94K107.88K98.98K108.13K
Net income per share
3.06K-1.47K2.13K1.2K2.31K
Operating cash flow per share
10.07K4.6K5.58K9.47K3.75K
Free cash flow per share
695.94-926.48726.053.87K-3.26K
Cash per share
14.25K12.85K12.58K16.61K16.29K
Book value per share
50.33K47.88K50.32K51.68K53.79K
Tangible book value per share
44.33K44.4K45.66K48.44K44.76K
Share holders equity per share
50.33K47.88K50.32K51.68K53.79K
Interest debt per share
38.11K38.41K39.05K42.79K42.76K
Market cap
1909.36B1909.36B1253.99B1615.37B1391.46B
Enterprise value
2203.3B2230.88B1614.82B1988.76B1761.24B
P/E ratio
60.46-126.0256.98126.6656.42
Price to sales ratio
1.991.851.131.531.21
POCF ratio
18.3740.221.771634.79
PFCF ratio
265.83-199.68167.3439.13-39.98
P/B Ratio
3.683.862.412.932.43
PTB ratio
3.683.862.412.932.43
EV to sales
2.292.161.451.881.53
Enterprise value over EBITDA
27.3236.8524.1937.0626.9
EV to operating cash flow
21.246.9728.0319.6944.04
EV to free cash flow
306.75-233.3215.548.17-50.61
Earnings yield
0.02-0.010.020.010.02
Free cash flow yield
0-0.010.010.03-0.03
Debt to equity
0.560.360.560.540.33
Debt to assets
0.480.50.490.490.5
Net debt to EBITDA
3.645.315.416.965.65
Current ratio
1.931.42.011.621.14
Interest coverage
4.712.564.431.68.67
Income quality
3.29-3.132.627.921.62
Dividend Yield
00000
Payout ratio
0.2-0.410.280.490.26
Sales general and administrative to revenue
0.030.030.020.020.02
Research and developement to revenue
0.110.110.10.110.11
Intangibles to total assets
0.140.120.130.130.16
Capex to operating cash flow
-0.93-1.2-0.87-0.59-1.87
Capex to revenue
-0.1-0.06-0.05-0.06-0.06
Capex to depreciation
-2.41-1.11-1.25-1.46-1.83
Stock based compensation to revenue
00000
Graham number
58.86K39.77K49.13K37.29K52.91K
ROIC
0.040.030.050.020.09
Return on tangible assets
0.03-0.010.020.010.02
Graham Net
-33.08K-36.13K-37.9K-38.22K-42.35K
Working capital
250.08B148.27B264.18B201.6B64.23B
Tangible asset value
457.56B458.24B471.23B516.51B477.24B
Net current asset value
-63.86B-84.37B-83.49B-143.31B-187.88B
Invested capital
0.740.780.760.810.78
Average receivables
00000
Average payables
69.11B70.52B77.74B78.78B74.82B
Average inventory
180.49B181.5B175.79B173.97B174.51B
Days sales outstanding
00000
Days payables outstanding
39.2136.5744.0847.2642.52
Days of inventory on hand
123.36111.02102.07104.36105.05
Receivables turnover
00000
Payables turnover
9.319.988.287.728.58
Inventory turnover
2.963.293.583.53.47
ROE
0.06-0.030.040.020.04
Capex per share
-9.37K-5.53K-4.85K-5.6K-7.01K

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
26.17K26.25K27.37K26.95K29.09K
Net income per share
553.149912.77K1.23K1.58K
Operating cash flow per share
228.231.92K1.54K2.21K1.41K
Free cash flow per share
-2.25K1.28K-762.55-594.446.56
Cash per share
16.19K17.07K15.69K015.41K
Book value per share
49.18K49.21K51.81K53.62K55.35K
Tangible book value per share
42.02K41.7K43.11K64.53K44.23K
Share holders equity per share
49.18K49.21K51.81K53.62K55.35K
Interest debt per share
40.15K40.11K40.51K-2.7439.85K
Market cap
1903.9B1610.76B1638.43B1815.56B1953.78B
Enterprise value
2287.21B1970.62B2008.22B1815.56B2278.41B
P/E ratio
77.7436.7113.3533.3327.96
Price to sales ratio
6.575.545.416.096.07
POCF ratio
753.6375.7795.9374.12125.49
PFCF ratio
-76.42113.56-194.09-275.913.79K
P/B Ratio
3.52.962.863.063.19
PTB ratio
3.52.962.863.063.19
EV to sales
7.96.786.636.097.07
Enterprise value over EBITDA
105.2772.7469.9358.6877.49
EV to operating cash flow
905.3592.69117.5874.12146.34
EV to free cash flow
-91.8138.93-237.89-275.914.42K
Earnings yield
00.010.020.010.01
Free cash flow yield
-0.010.01-0.0100
Debt to equity
0.370.530.3300.41
Debt to assets
0.520.520.50.510.51
Net debt to EBITDA
17.6413.2812.88011.04
Current ratio
1.181.461.141.141.38
Interest coverage
009.03-760.3-5.52
Income quality
0.411.940.561.80.89
Dividend Yield
00000
Payout ratio
0000.040.38
Sales general and administrative to revenue
0.020.020.020.40.02
Research and developement to revenue
0.120.110.100.12
Intangibles to total assets
0.150.150.1600.17
Capex to operating cash flow
-10.86-0.33-1.49-1.27-0.97
Capex to revenue
-0.09-0.02-0.08-0.1-0.05
Capex to depreciation
-2.67-0.69-2.5-3.12-1.55
Stock based compensation to revenue
00000
Graham number
24.74K33.13K56.83K38.53K44.33K
ROIC
0.020.020.030.020.03
Return on tangible assets
0.010.010.030.010.01
Graham Net
-40.51K-40.37K-40.79K-66.98K-44.21K
Working capital
82.1B172.54B64.23B66.11B157.3B
Tangible asset value
465.08B461.69B477.24B0489.63B
Net current asset value
-188.77B-182.84B-187.88B-202.93B-190.03B
Invested capital
0.820.820.7800.73
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
42.7543.3840.29049.87
Days of inventory on hand
106.79104.9699.540112.84
Receivables turnover
00000
Payables turnover
2.112.072.2301.8
Inventory turnover
0.840.860.900.8
ROE
0.010.020.050.020.03
Capex per share
-2.48K-639.09-2.31K-2.81K-1.36K

Frequently Asked Questions

What is Daewoong pharmaceutical Co.,Ltd stock symbol ?

Daewoong pharmaceutical Co.,Ltd is a US stock and trading under the symbol 069620.KS

What is Daewoong pharmaceutical Co.,Ltd stock quote today ?

Daewoong pharmaceutical Co.,Ltd stock price is $157500 today.

Is Daewoong pharmaceutical Co.,Ltd stock public?

Yes, Daewoong pharmaceutical Co.,Ltd is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks